Combined with relevant studies and our experimental results, we proposed the scientific hypothesis that IL-17A may be involved in the development of lung cancer in NSCLC by modulating tumor cell autophagy, altering the tumor microenvironment, improving PD-L1 expression in cancer cells, and promoting local immune cell exhaustion and immune escape of cancer cells. This evidence concerns the gene IL17A and lung carcinoma.